Recently Released Market Study: Brazil Pharmaceuticals & Healthcare Report Q4 2012
BMI View: The Brazilian pharmaceutical market is still our favourite regional market in Latin America despite the recent downgrade in our Risk/Reward Ratings. The government has increasingly invested in the healthcare sector and pharmaceutical industry to stimulate local production capacity, reduce the financial burden of diseases and lessen the country's trade deficit. Multinationals can capitalise on the strong growth of the market by introducing innovative, high-tech products and collaborating with local companies.
View full press release